Arkolith/Insider Trading/NBRV/Form 4

Naftzger J. Christopher

General Counsel and Corp SecNabriva Therapeutics plc (NBRV) · full profile →Form 4 · filed Dec 28, 2021
Net Buying
Open-Market Buys
$4K
Open-Market Sells
$0
Net Open-Market Flow
$4K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 27, 2021Buy(P)7K$0.59$4K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-154012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML